PSUSA/00010072/202409
Submitted by Anonymous (not verified) on 12 May 2025 - 14:32
PSUSA/00010072/202409
PSUSA/00010072/202409
PSUSA/00010670/202409
Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Date of authorisation: 12/12/2007, Revision: 32, Status: Authorised
Medicine shortage communication (MSC): Fiasp PumpCart and NovoRapid PumpCart
Opinion/decision on a Paediatric investigation plan (PIP): Rinvoq, upadacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0079/2024
EMEA-003130-PIP02-23
Agenda - EMA’s 30th anniversary scientific conference
Careers
Who we are
EMA Gender equality plan 2025 - 2030